Intriguingly, inhibition of BRD4 by a small molecule inhibitor, such as JQ1 or I-BET151, improves NASH fibrosis and cardiac fibrosis in rodent models (29–32). This evidence concerns the gene BRD4 and metabolic dysfunction-associated steatohepatitis.